Literature DB >> 19282142

The use of virtual reality in acrophobia research and treatment.

Carlos M Coelho1, Allison M Waters, Trevor J Hine, Guy Wallis.   

Abstract

Acrophobia, or fear of heights, is a widespread and debilitating anxiety disorder affecting perhaps 1 in 20 adults. Virtual reality (VR) technology has been used in the psychological treatment of acrophobia since 1995, and has come to dominate the treatment of numerous anxiety disorders. It is now known that virtual reality exposure therapy (VRET) regimens are highly effective for acrophobia treatment. This paper reviews current theoretical understanding of acrophobia as well as the evolution of its common treatments from the traditional exposure therapies to the most recent virtually guided ones. In particular, the review focuses on recent innovations in the use of VR technology and discusses the benefits it may offer for examining the underlying causes of the disorder, allowing for the systematic assessment of interrelated factors such as the visual, vestibular and postural control systems.

Entities:  

Mesh:

Year:  2009        PMID: 19282142     DOI: 10.1016/j.janxdis.2009.01.014

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  16 in total

1.  Healing anxiety disorders with glucocorticoids.

Authors:  Carmen Sandi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

Review 2.  mHealth: a mechanism to deliver more accessible, more effective mental health care.

Authors:  Matthew Price; Erica K Yuen; Elizabeth M Goetter; James D Herbert; Evan M Forman; Ron Acierno; Kenneth J Ruggiero
Journal:  Clin Psychol Psychother       Date:  2013-08-05

3.  The feasibility and acceptability of virtual environments in the treatment of childhood social anxiety disorder.

Authors:  Nina Wong Sarver; Deborah C Beidel; Josh S Spitalnick
Journal:  J Clin Child Adolesc Psychol       Date:  2013-10-21

4.  Self-efficacy beliefs are associated with visual height intolerance: a cross-sectional survey.

Authors:  Eva Grill; Florian Schäffler; Doreen Huppert; Martin Müller; Hans-Peter Kapfhammer; Thomas Brandt
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

5.  Susceptibility to Fear of Heights in Bilateral Vestibulopathy and Other Disorders of Vertigo and Balance.

Authors:  Thomas Brandt; Eva Grill; Michael Strupp; Doreen Huppert
Journal:  Front Neurol       Date:  2018-06-06       Impact factor: 4.003

6.  Adaptation of emotional state and standing balance parameters following repeated exposure to height-induced postural threat.

Authors:  Martin Zaback; Allan L Adkin; Mark G Carpenter
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

7.  Effectiveness of cognitive behavioral therapy integrated with systematic desensitization, cognitive behavioral therapy combined with eye movement desensitization and reprocessing therapy, and cognitive behavioral therapy combined with virtual reality exposure therapy methods in the treatment of flight anxiety: a randomized trial.

Authors:  Maria Teresa Triscari; Palmira Faraci; Dario Catalisano; Valerio D'Angelo; Viviana Urso
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-07       Impact factor: 2.570

8.  Brain metabolism and related connectivity in patients with acrophobia treated by virtual reality therapy: an 18F-FDG PET pilot study sensitized by virtual exposure.

Authors:  Antoine Verger; Eric Malbos; Emmanuelle Reynaud; Pierre Mallet; Daniel Mestre; Jean-Marie Pergandi; Stéphanie Khalfa; Eric Guedj
Journal:  EJNMMI Res       Date:  2018-10-01       Impact factor: 3.138

9.  Neuroticism modulates brain visuo-vestibular and anxiety systems during a virtual rollercoaster task.

Authors:  Roberta Riccelli; Iole Indovina; Jeffrey P Staab; Salvatore Nigro; Antonio Augimeri; Francesco Lacquaniti; Luca Passamonti
Journal:  Hum Brain Mapp       Date:  2016-09-28       Impact factor: 5.038

Review 10.  Height intolerance between physiological mechanisms and psychological distress: a review of literature and our experience.

Authors:  R Teggi; F Comacchio; F Fornasari; E Mira
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-08       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.